Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Biol. Chem. 277 (44): 42394-42398

© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2*

Liangyou RuiDagger §, Minsheng YuanDagger , Daniel FrantzDagger , Steven ShoelsonDagger , and Morris F. WhiteDagger ||

From the  Howard Hughes Medical Institute, Dagger  Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215

Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.


* This work was supported by National Research Service Award (to L. R.) and National Institutes of Health grants (to S. S. and M. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: Dept. of Physiology, University of Michigan Medical School, Ann Arbor, MI 48109.

|| To whom correspondence should be addressed: Howard Hughes Medical Inst., Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215. Tel.: 617-732-2578; Fax: 617-732-2593; E-mail: whitemor@joslab.harvard.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
J. Hoefer, J. Kern, P. Ofer, I. E. Eder, G. Schafer, D. Dietrich, G. Kristiansen, S. Geley, J. Rainer, E. Gunsilius, et al. (2014)
Endocr. Relat. Cancer 21, 175-187
   Abstract »    Full Text »    PDF »
Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.
T. Hartmann, X. Xu, M. Kronast, S. Muehlich, K. Meyer, W. Zimmermann, J. Hurwitz, Z.-Q. Pan, S. Engelhardt, and A. Sarikas (2014)
PNAS 111, 3371-3376
   Abstract »    Full Text »    PDF »
Adipocytokines in obesity and metabolic disease.
H. Cao (2014)
J. Endocrinol. 220, T47-T59
   Abstract »    Full Text »    PDF »
Therapeutic Effects of Suppressors of Cytokine Signaling in Diabetic Nephropathy.
Q. Liu, L. Xing, L. Wang, F. Yao, S. Liu, J. Hao, W. Liu, and H. Duan (2014)
Journal of Histochemistry & Cytochemistry 62, 119-128
   Abstract »    Full Text »    PDF »
Insulin Receptor Signaling in Normal and Insulin-Resistant States.
J. Boucher, A. Kleinridders, and C. R. Kahn (2014)
Cold Spring Harb Perspect Biol 6, a009191
   Abstract »    Full Text »    PDF »
Phosphorylation of Serine 1137/1138 of Mouse Insulin Receptor Substrate (IRS) 2 Regulates cAMP-dependent Binding to 14-3-3 Proteins and IRS2 Protein Degradation.
S. S. Neukamm, J. Ott, S. Dammeier, R. Lehmann, H.-U. Haring, E. Schleicher, and C. Weigert (2013)
J. Biol. Chem. 288, 16403-16415
   Abstract »    Full Text »    PDF »
Stability, delivery and functions of human sperm RNAs at fertilization.
E. Sendler, G. D. Johnson, S. Mao, R. J. Goodrich, M. P. Diamond, R. Hauser, and S. A. Krawetz (2013)
Nucleic Acids Res. 41, 4104-4117
   Abstract »    Full Text »    PDF »
Altered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients.
L. Q. Jiang, D. E. Duque-Guimaraes, U. F. Machado, J. R. Zierath, and A. Krook (2013)
Diabetes 62, 355-361
   Abstract »    Full Text »    PDF »
Constitutive STAT3 Phosphorylation Contributes to Skeletal Muscle Insulin Resistance in Type 2 Diabetes.
F. Mashili, A. V. Chibalin, A. Krook, and J. R. Zierath (2013)
Diabetes 62, 457-465
   Abstract »    Full Text »    PDF »
Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity.
S. B. Jorgensen, H. M. O'Neill, L. Sylow, J. Honeyman, K. A. Hewitt, R. Palanivel, M. D. Fullerton, L. Oberg, A. Balendran, S. Galic, et al. (2013)
Diabetes 62, 56-64
   Abstract »    Full Text »    PDF »
Suppressors of Cytokine Signaling Promote Fas-Induced Apoptosis through Downregulation of NF-{kappa}B and Mitochondrial Bfl-1 in Leukemic T Cells.
J. Oh, S.-H. Kim, S. Ahn, and C.-E. Lee (2012)
J. Immunol. 189, 5561-5571
   Abstract »    Full Text »    PDF »
Identification of the Degradation Determinants of Insulin Receptor Substrate 1 for Signaling Cullin-RING E3 Ubiquitin Ligase 7-mediated Ubiquitination.
X. Xu, M. Keshwani, K. Meyer, A. Sarikas, S. Taylor, and Z.-Q. Pan (2012)
J. Biol. Chem. 287, 40758-40766
   Abstract »    Full Text »    PDF »
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia.
J. D. Sparks, C. E. Sparks, and K. Adeli (2012)
Arterioscler Thromb Vasc Biol 32, 2104-2112
   Abstract »    Full Text »    PDF »
SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice.
F. Zadjali, R. Santana-Farre, M. Vesterlund, B. Carow, M. Mirecki-Garrido, I. Hernandez-Hernandez, M. Flodstrom-Tullberg, P. Parini, M. Rottenberg, G. Norstedt, et al. (2012)
FASEB J 26, 3282-3291
   Abstract »    Full Text »    PDF »
Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes.
A. J. Gerrits, E. Gitz, C. A. Koekman, F. L. Visseren, T. W. van Haeften, and J. W. N. Akkerman (2012)
Haematologica 97, 1149-1157
   Abstract »    Full Text »    PDF »
Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3.
Y. Gao, V. Cimica, and N. C. Reich (2012)
J. Biol. Chem. 287, 20904-20912
   Abstract »    Full Text »    PDF »
Amyloid-{beta} Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway.
Y. Zhang, B. Zhou, F. Zhang, J. Wu, Y. Hu, Y. Liu, and Q. Zhai (2012)
Diabetes 61, 1434-1443
   Abstract »    Full Text »    PDF »
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights.
N. S. Kalupahana, K. J. Claycombe, and N. Moustaid-Moussa (2011)
Adv Nutr 2, 304-316
   Abstract »    Full Text »    PDF »
Suppression of FoxO1 Activity by Long-Chain Fatty Acyl Analogs.
G. Zatara, R. Hertz, M. Shaked, N. Mayorek, E. Morad, E. Grad, A. Cahan, H. D. Danenberg, T. G. Unterman, and J. Bar-Tana (2011)
Diabetes 60, 1872-1881
   Abstract »    Full Text »    PDF »
Activation of Peroxisome Proliferator-Activated Receptor-{beta}/-{delta} (PPAR-{beta}/-{delta}) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6-Stimulated Adipocytes.
L. Serrano-Marco, R. Rodriguez-Calvo, I. El Kochairi, X. Palomer, L. Michalik, W. Wahli, and M. Vazquez-Carrera (2011)
Diabetes 60, 1990-1999
   Abstract »    Full Text »    PDF »
Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
T. Wada, M. Hoshino, Y. Kimura, M. Ojima, T. Nakano, D. Koya, H. Tsuneki, and T. Sasaoka (2011)
Am J Physiol Endocrinol Metab 300, E1112-E1123
   Abstract »    Full Text »    PDF »
Genetic Ablation of cGMP-Dependent Protein Kinase Type I Causes Liver Inflammation and Fasting Hyperglycemia.
S. Z. Lutz, A. M. Hennige, S. Feil, A. Peter, A. Gerling, J. Machann, S. M. Krober, M. Rath, A. Schurmann, C. Weigert, et al. (2011)
Diabetes 60, 1566-1576
   Abstract »    Full Text »    PDF »
Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.
L. Fritsche, S. S. Neukamm, R. Lehmann, E. Kremmer, A. M. Hennige, A. Hunder-Gugel, M. Schenk, H.-U. Haring, E. D. Schleicher, and C. Weigert (2011)
Am J Physiol Endocrinol Metab 300, E824-E836
   Abstract »    Full Text »    PDF »
Leptin and the Central Nervous System Control of Glucose Metabolism.
G. J. Morton and M. W. Schwartz (2011)
Physiol Rev 91, 389-411
   Abstract »    Full Text »    PDF »
Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance.
J. W. Perfield II, Y. Lee, G. I. Shulman, V. T. Samuel, M. J. Jurczak, E. Chang, C. Xie, P. N. Tsichlis, M. S. Obin, and A. S. Greenberg (2011)
Diabetes 60, 1168-1176
   Abstract »    Full Text »    PDF »
Viral Exploitation of Host SOCS Protein Functions.
L. N. Akhtar and E. N. Benveniste (2011)
J. Virol. 85, 1912-1921
   Abstract »    Full Text »    PDF »
Lipocalin-13 Regulates Glucose Metabolism by both Insulin-Dependent and Insulin-Independent Mechanisms.
K. W. Cho, Y. Zhou, L. Sheng, and L. Rui (2011)
Mol. Cell. Biol. 31, 450-457
   Abstract »    Full Text »    PDF »
Suppressor of Cytokine Signaling-3 Is a Glucagon-inducible Inhibitor of PKA Activity and Gluconeogenic Gene Expression in Hepatocytes.
A. M. Gaudy, A. H. Clementi, J. S. Campbell, A. V. Smrcka, and R. A. Mooney (2010)
J. Biol. Chem. 285, 41356-41365
   Abstract »    Full Text »    PDF »
Requirement of JIP1-Mediated c-Jun N-Terminal Kinase Activation for Obesity-Induced Insulin Resistance.
C. Morel, C. L. Standen, D. Y. Jung, S. Gray, H. Ong, R. A. Flavell, J. K. Kim, and R. J. Davis (2010)
Mol. Cell. Biol. 30, 4616-4625
   Abstract »    Full Text »    PDF »
Discovery and characterization of nutritionally regulated genes associated with muscle growth in Atlantic salmon.
N. I. Bower and I. A. Johnston (2010)
Physiol Genomics 42A, 114-130
   Abstract »    Full Text »    PDF »
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor {alpha} expression.
A. R. Moschen, C. Molnar, S. Geiger, I. Graziadei, C. F. Ebenbichler, H. Weiss, S. Kaser, A. Kaser, and H. Tilg (2010)
Gut 59, 1259-1264
   Abstract »    Full Text »    PDF »
Glycogen synthase kinase 3{beta} mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1.
S. Leng, W. Zhang, Y. Zheng, Z. Liberman, C. J. Rhodes, H. Eldar-Finkelman, and X. J. Sun (2010)
J. Endocrinol. 206, 171-181
   Abstract »    Full Text »    PDF »
Adenovirus infection results in alterations of insulin signaling and glucose homeostasis.
S. Jiang, T. A. Gavrikova, A. Pereboev, and J. L. Messina (2010)
Am J Physiol Endocrinol Metab 298, E1295-E1304
   Abstract »    Full Text »    PDF »
Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3.
R. Deopurkar, H. Ghanim, J. Friedman, S. Abuaysheh, C. L. Sia, P. Mohanty, P. Viswanathan, A. Chaudhuri, and P. Dandona (2010)
Diabetes Care 33, 991-997
   Abstract »    Full Text »    PDF »
Establishment of a Mammary Stromal Fibroblastic Cell Line for In Vitro Studies in Mice of Mammary Adipocyte Differentiation.
H. Nakatani, N. Aoki, T. Okajima, D. Nadano, D. Flint, and T. Matsuda (2010)
Biol Reprod 82, 44-53
   Abstract »    Full Text »    PDF »
Interferon {gamma} Attenuates Insulin Signaling, Lipid Storage, and Differentiation in Human Adipocytes via Activation of the JAK/STAT Pathway.
F. C. McGillicuddy, E. H. Chiquoine, C. C. Hinkle, R. J. Kim, R. Shah, H. M. Roche, E. M. Smyth, and M. P. Reilly (2009)
J. Biol. Chem. 284, 31936-31944
   Abstract »    Full Text »    PDF »
Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the Heart.
H. J. Ko, Z. Zhang, D. Y. Jung, J. Y. Jun, Z. Ma, K. E. Jones, S. Y. Chan, and J. K. Kim (2009)
Diabetes 58, 2536-2546
   Abstract »    Full Text »    PDF »
Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng.
Y. Wang, P. M Nishina, and J. K Naggert (2009)
J. Endocrinol. 203, 65-74
   Abstract »    Full Text »    PDF »
Signal Transduction Cross Talk Mediated by Jun N-Terminal Kinase-Interacting Protein and Insulin Receptor Substrate Scaffold Protein Complexes.
C. L. Standen, N. J. Kennedy, R. A. Flavell, and R. J. Davis (2009)
Mol. Cell. Biol. 29, 4831-4840
   Abstract »    Full Text »    PDF »
Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading.
R. Nakao, K. Hirasaka, J. Goto, K. Ishidoh, C. Yamada, A. Ohno, Y. Okumura, I. Nonaka, K. Yasutomo, K. M. Baldwin, et al. (2009)
Mol. Cell. Biol. 29, 4798-4811
   Abstract »    Full Text »    PDF »
SH2B1 Enhances Insulin Sensitivity by Both Stimulating the Insulin Receptor and Inhibiting Tyrosine Dephosphorylation of Insulin Receptor Substrate Proteins.
D. L. Morris, K. W. Cho, Y. Zhou, and L. Rui (2009)
Diabetes 58, 2039-2047
   Abstract »    Full Text »    PDF »
Activation of Protein Kinase C{alpha} by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein {beta}-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells.
G. Borland, R. J. Bird, T. M. Palmer, and S. J. Yarwood (2009)
J. Biol. Chem. 284, 17391-17403
   Abstract »    Full Text »    PDF »
High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKK{alpha}/{beta} phosphorylation and decreases PI-3 kinase activity in muscle.
B. B. Yaspelkis III, I. A. Kvasha, and T. Y. Figueroa (2009)
Am J Physiol Regulatory Integrative Comp Physiol 296, R1709-R1715
   Abstract »    Full Text »    PDF »
Identification of MUP1 as a Regulator for Glucose and Lipid Metabolism in Mice.
Y. Zhou, L. Jiang, and L. Rui (2009)
J. Biol. Chem. 284, 11152-11159
   Abstract »    Full Text »    PDF »
SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases.
J. Elliott, Y. Suessmuth, L. M. Scott, K. Nahlik, M. F. McMullin, S. N. Constantinescu, A. R. Green, and J. A. Johnston (2009)
Haematologica 94, 576-580
   Abstract »    Full Text »    PDF »
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting.
L. Zhang, J. Du, Z. Hu, G. Han, P. Delafontaine, G. Garcia, and W. E. Mitch (2009)
J. Am. Soc. Nephrol. 20, 604-612
   Abstract »    Full Text »    PDF »
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance.
G. Sabio, M. Das, A. Mora, Z. Zhang, J. Y. Jun, H. J. Ko, T. Barrett, J. K. Kim, and R. J. Davis (2008)
Science 322, 1539-1543
   Abstract »    Full Text »    PDF »
Adipose Inflammation, Insulin Resistance, and Cardiovascular Disease.
A. Shah, N. Mehta, and M. P. Reilly (2008)
JPEN J Parenter Enteral Nutr 32, 638-644
   Abstract »    Full Text »    PDF »
Muscle-Specific IRS-1 Ser->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle.
K. Morino, S. Neschen, S. Bilz, S. Sono, D. Tsirigotis, R. M. Reznick, I. Moore, Y. Nagai, V. Samuel, D. Sebastian, et al. (2008)
Diabetes 57, 2644-2651
   Abstract »    Full Text »    PDF »
Regulation of the O-Linked {beta}-N-Acetylglucosamine Transferase by Insulin Signaling.
S. A. Whelan, M. D. Lane, and G. W. Hart (2008)
J. Biol. Chem. 283, 21411-21417
   Abstract »    Full Text »    PDF »
Chlorpromazine attenuates pancreatic {beta}-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation.
S. Park, S. Hong, J. Lee, S. Sung, and S. Kim (2008)
J Psychopharmacol 22, 522-531
   Abstract »    PDF »
Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells.
X. Liu, M. G. Mameza, Y. S. Lee, C. I. Eseonu, C.-R. Yu, J. J. Kang Derwent, and C. E. Egwuagu (2008)
Diabetes 57, 1651-1658
   Abstract »    Full Text »    PDF »
Regulation of mammary parenchymal growth by the fat pad in prepubertal dairy heifers: role of inflammation-related proteins.
S. R Thorn, S. Purup, M. Vestergaard, K. Sejrsen, M. J Meyer, M. E Van Amburgh, and Y. R Boisclair (2008)
J. Endocrinol. 196, 539-546
   Abstract »    Full Text »    PDF »
HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus.
M. J. Carper, W. T. Cade, M. Cam, S. Zhang, A. Shalev, K. E. Yarasheski, and S. Ramanadham (2008)
Am J Physiol Endocrinol Metab 294, E558-E567
   Abstract »    Full Text »    PDF »
The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
K. Boyle, P. Egan, S. Rakar, T. A. Willson, I. P. Wicks, D. Metcalf, D. J. Hilton, N. A. Nicola, W. S. Alexander, A. W. Roberts, et al. (2007)
Blood 110, 1466-1474
   Abstract »    Full Text »    PDF »
Mechanisms of obesity-associated insulin resistance: many choices on the menu.
M. Qatanani and M. A. Lazar (2007)
Genes & Dev. 21, 1443-1455
   Abstract »    Full Text »    PDF »
Reciprocal Regulation of SOCS 1 and SOCS3 Enhances Resistance to Ionizing Radiation in Glioblastoma Multiforme.
H. Zhou, R. Miki, M. Eeva, F. M. Fike, D. Seligson, L. Yang, A. Yoshimura, M. A. Teitell, C. A.M. Jamieson, and N. A. Cacalano (2007)
Clin. Cancer Res. 13, 2344-2353
   Abstract »    Full Text »    PDF »
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
S. Brand, J. Dambacher, F. Beigel, K. Zitzmann, M. H. J. Heeg, T. S. Weiss, T. Prufer, T. Olszak, C. J. Steib, M. Storr, et al. (2007)
Am J Physiol Gastrointest Liver Physiol 292, G1019-G1028
   Abstract »    Full Text »    PDF »
Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression: Potential Mechanisms for Its Effects on Insulin Sensitivity and Adiponectin Expression.
Y. Kanatani, I. Usui, K. Ishizuka, A. Bukhari, S. Fujisaka, M. Urakaze, T. Haruta, T. Kishimoto, T. Naka, and M. Kobayashi (2007)
Diabetes 56, 795-803
   Abstract »    Full Text »    PDF »
SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated Responses.
S. J. Orr, N. M. Morgan, R. J. Buick, C. R. Boyd, J. Elliott, J. F. Burrows, C. A. Jefferies, P. R. Crocker, and J. A. Johnston (2007)
J. Biol. Chem. 282, 3418-3422
   Abstract »    Full Text »    PDF »
COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS.
R. A. Mooney (2007)
J Appl Physiol 102, 816-818
   Full Text »    PDF »
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
B. K. Pedersen, M. A. Febbraio, and R. A. Mooney (2007)
J Appl Physiol 102, 814-816
   Full Text »    PDF »
Diabetes and Suppressors of Cytokine Signaling Proteins.
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen (2007)
Diabetes 56, 541-548
   Full Text »    PDF »
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.
S. J. Orr, N. M. Morgan, J. Elliott, J. F. Burrows, C. J. Scott, D. W. McVicar, and J. A. Johnston (2007)
Blood 109, 1061-1068
   Abstract »    Full Text »    PDF »
COMMD1 promotes the ubiquitination of NF-{kappa}B subunits through a cullin-containing ubiquitin ligase.
G. N. Maine, X. Mao, C. M. Komarck, and E. Burstein (2007)
EMBO J. 26, 436-447
   Abstract »    Full Text »    PDF »
Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.
C. N. Lumeng, S. M. Deyoung, and A. R. Saltiel (2007)
Am J Physiol Endocrinol Metab 292, E166-E174
   Abstract »    Full Text »    PDF »
Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling.
J. Piessevaux, D. Lavens, T. Montoye, J. Wauman, D. Catteeuw, J. Vandekerckhove, D. Belsham, F. Peelman, and J. Tavernier (2006)
J. Biol. Chem. 281, 32953-32966
   Abstract »    Full Text »    PDF »
Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons..
T. Miao, D. Wu, Y. Zhang, X. Bo, M. C. Subang, P. Wang, and P. M. Richardson (2006)
J. Neurosci. 26, 9512-9519
   Abstract »    Full Text »    PDF »
Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells.
W. A. Sands, H. D. Woolson, G. R. Milne, C. Rutherford, and T. M. Palmer (2006)
Mol. Cell. Biol. 26, 6333-6346
   Abstract »    Full Text »    PDF »
Grb10 mediates insulin-stimulated degradation of the insulin receptor: a mechanism of negative regulation.
F. J. Ramos, P. R. Langlais, D. Hu, L. Q. Dong, and F. Liu (2006)
Am J Physiol Endocrinol Metab 290, E1262-E1266
   Abstract »    Full Text »    PDF »
Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression.
E. E. Spangenburg, D. A. Brown, M. S. Johnson, and R. L. Moore (2006)
J. Physiol. 572, 839-848
   Abstract »    Full Text »    PDF »
Overexpression of Suppressor of Cytokine Signaling 3 in Adipose Tissue Causes Local but Not Systemic Insulin Resistance.
H. Shi, B. Cave, K. Inouye, C. Bjorbaek, and J. S. Flier (2006)
Diabetes 55, 699-707
   Abstract »    Full Text »    PDF »
Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice.
K Inagaki-Ohara, A Sasaki, G Matsuzaki, T Ikeda, M Hotokezaka, K Chijiiwa, M Kubo, H Yoshida, Y Nawa, and A Yoshimura (2006)
Gut 55, 212-219
   Abstract »    Full Text »    PDF »
Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
T. Ben-Zvi, A. Yayon, A. Gertler, and E. Monsonego-Ornan (2006)
J. Cell Sci. 119, 380-387
   Abstract »    Full Text »    PDF »
The Emerging Role of the COP9 Signalosome in Cancer.
K. S. Richardson and W. Zundel (2005)
Mol. Cancer Res. 3, 645-653
   Abstract »    Full Text »    PDF »
Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization.
T. Landsman and D. J. Waxman (2005)
J. Biol. Chem. 280, 37471-37480
   Abstract »    Full Text »    PDF »
JNK and Tumor Necrosis Factor-{alpha} Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes.
M. T. A. Nguyen, H. Satoh, S. Favelyukis, J. L. Babendure, T. Imamura, J. I. Sbodio, J. Zalevsky, B. I. Dahiyat, N.-W. Chi, and J. M. Olefsky (2005)
J. Biol. Chem. 280, 35361-35371
   Abstract »    Full Text »    PDF »
SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation.
G. M. Tannahill, J. Elliott, A. C. Barry, L. Hibbert, N. A. Cacalano, and J. A. Johnston (2005)
Mol. Cell. Biol. 25, 9115-9126
   Abstract »    Full Text »    PDF »
Physical activity and modulation of systemic low-level inflammation.
H. Bruunsgaard (2005)
J. Leukoc. Biol. 78, 819-835
   Abstract »    Full Text »    PDF »
JAK/STAT3 Pathway Is Involved in Survival of Neurons in Response to Insulin-like Growth Factor and Negatively Regulated by Suppressor of Cytokine Signaling-3.
A. Yadav, A. Kalita, S. Dhillon, and K. Banerjee (2005)
J. Biol. Chem. 280, 31830-31840
   Abstract »    Full Text »    PDF »
Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation: CONTRIBUTIONS OF Src- AND RECEPTOR-TYROSINE KINASES.
U. Sommer, C. Schmid, R. M. Sobota, U. Lehmann, N. J. Stevenson, J. A. Johnston, F. Schaper, P. C. Heinrich, and S. Haan (2005)
J. Biol. Chem. 280, 31478-31488
   Abstract »    Full Text »    PDF »
Socs1 Deficiency Enhances Hepatic Insulin Signaling.
E. Jamieson, M. M. W. Chong, G. R. Steinberg, V. Jovanovska, B. C. Fam, D. V. R. Bullen, Y. Chen, B. E. Kemp, J. Proietto, T. W. H. Kay, et al. (2005)
J. Biol. Chem. 280, 31516-31521
   Abstract »    Full Text »    PDF »
Adipocyte-Specific Overexpression of FOXC2 Prevents Diet-Induced Increases in Intramuscular Fatty Acyl CoA and Insulin Resistance.
J. K. Kim, H.-J. Kim, S.-Y. Park, A. Cederberg, R. Westergren, D. Nilsson, T. Higashimori, Y.-R. Cho, Z.-X. Liu, J. Dong, et al. (2005)
Diabetes 54, 1657-1663
   Abstract »    Full Text »    PDF »
Human biliverdin reductase: A member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.
N. Lerner-Marmarosh, J. Shen, M. D. Torno, A. Kravets, Z. Hu, and M. D. Maines (2005)
PNAS 102, 7109-7114
   Abstract »    Full Text »    PDF »
Suppressor of Cytokine Signaling 7 Inhibits Prolactin, Growth Hormone, and Leptin Signaling by Interacting with STAT5 or STAT3 and Attenuating Their Nuclear Translocation.
N. Martens, G. Uzan, M. Wery, R. Hooghe, E. L. Hooghe-Peters, and A. Gertler (2005)
J. Biol. Chem. 280, 13817-13823
   Abstract »    Full Text »    PDF »
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation.
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg (2005)
Circulation 111, 1448-1454
   Full Text »    PDF »
Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling.
E. Kario, M. D. Marmor, K. Adamsky, A. Citri, I. Amit, N. Amariglio, G. Rechavi, and Y. Yarden (2005)
J. Biol. Chem. 280, 7038-7048
   Abstract »    Full Text »    PDF »
Activation of SOCS-3 by Resistin.
C. M. Steppan, J. Wang, E. L. Whiteman, M. J. Birnbaum, and M. A. Lazar (2005)
Mol. Cell. Biol. 25, 1569-1575
   Abstract »    Full Text »    PDF »
Type 2 Diabetes-a Matter of {beta}-Cell Life and Death?.
C. J. Rhodes (2005)
Science 307, 380-384
   Abstract »    Full Text »    PDF »
Role of Tyrosine 441 of Interferon-{gamma} Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation.
Y. Qing, A. P. Costa-Pereira, D. Watling, and G. R. Stark (2005)
J. Biol. Chem. 280, 1849-1853
   Abstract »    Full Text »    PDF »
Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells.
I. Briaud, L. M. Dickson, M. K. Lingohr, J. F. McCuaig, J. C. Lawrence, and C. J. Rhodes (2005)
J. Biol. Chem. 280, 2282-2293
   Abstract »    Full Text »    PDF »
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
T. Kamura, K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway, and K. I. Nakayama (2004)
Genes & Dev. 18, 3055-3065
   Abstract »    Full Text »    PDF »
Metabolic Syndrome and Robustness Tradeoffs.
H. Kitano, K. Oda, T. Kimura, Y. Matsuoka, M. Csete, J. Doyle, and M. Muramatsu (2004)
Diabetes 53, S6-S15
   Abstract »    Full Text »    PDF »
{beta}-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1.
I. Usui, T. Imamura, J. Huang, H. Satoh, S. K. Shenoy, R. J. Lefkowitz, C. J. Hupfeld, and J. M. Olefsky (2004)
Mol. Cell. Biol. 24, 8929-8937
   Abstract »    Full Text »    PDF »
SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome.
B. Q. Vuong, T. L. Arenzana, B. M. Showalter, J. Losman, X. P. Chen, J. Mostecki, A. S. Banks, A. Limnander, N. Fernandez, and P. B. Rothman (2004)
Mol. Cell. Biol. 24, 9092-9101
   Abstract »    Full Text »    PDF »
SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin.
C. Duan, M. Li, and L. Rui (2004)
J. Biol. Chem. 279, 43684-43691
   Abstract »    Full Text »    PDF »
Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.
A. Ahmad and F. Alvarez (2004)
J. Leukoc. Biol. 76, 743-759
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882